Sandy Smith

Track

Insider profile

Currently holds positions in Genzyme Corp, Palisade Bio Inc and Akcea Therapeutics Inc

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 76% 68% 82%
Transactions
13 15% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President, President - International Group Genzyme Corp June 1, 2006 -
Independent Director Palisade Bio Inc March 1, 2014 -
Independent Director Akcea Therapeutics Inc March 15, 2017 -
Independent Director Seelos Therapeutics Inc Aug. 5, 2014 - Jan. 24, 2019
Sandy Smith's trades of Cytokinetics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-09-02 2022-09-02
S Sale
20,449 -11.1%
305.25
US$2,051,847 		20,449 -11.1% 305.25 US$2,051,847
2021-11-19 2021-11-19
S Sale
73,422 -1.7%
408.20
US$4,678,827 		73,422 -1.7% 408.20 US$4,678,827
2021-11-19 2021-11-19
S Sale
1,171 +21.5%
63.10
US$1,146,596 		1,171 +21.5% 63.10 US$1,146,596
2021-11-19 2021-11-19
S Sale
5,000 -42.5%
41.21
US$206,027 		5,000 -42.5% 41.21 US$206,027
2021-07-21 2021-07-19
PlS Planned sale
5,000 -43.6%
28.50
US$142,500 		5,000 -43.6% 28.50 US$142,500
2021-07-21 2021-07-19
PlS Planned sale
1,965 -23.3%
29.50
US$57,968 		1,965 -23.3% 29.50 US$57,968
2021-07-21 2021-07-19
PlS Planned sale
5,000 -43.6%
29.00
US$145,000 		5,000 -43.6% 29.00 US$145,000
2021-04-27 2021-04-27
PlS Planned sale
5,000 -84.5%
28.00
US$140,000 		5,000 -84.5% 28.00 US$140,000
2021-04-27 2021-04-27
PlS Planned sale
4,739 -83.7%
27.50
US$130,322 		4,739 -83.7% 27.50 US$130,322
2021-04-23 2021-04-23
PlS Planned sale
5,000 -84.5%
26.50
US$132,500 		5,000 -84.5% 26.50 US$132,500
2021-04-15 2021-04-15
PlS Planned sale
5,714 -86.1%
25.00
US$142,850 		5,714 -86.1% 25.00 US$142,850
2021-04-15 2021-04-15
PlS Planned sale
5,000 -84.5%
25.50
US$127,500 		5,000 -84.5% 25.50 US$127,500
2020-10-05 2020-10-05
PlS Planned sale
5,936 -100.0%
30.00
US$178,080 		5,936 -100.0% 30.00 US$178,080
2020-07-17 2020-07-15
PlS Planned sale
6,667 -100.0%
29.00
US$193,343 		6,667 -100.0% 29.00 US$193,343
2020-07-13 2020-07-10
PlS Planned sale
6,667 -100.0%
28.00
US$186,676 		6,667 -100.0% 28.00 US$186,676
2020-07-09 2020-07-08
PlS Planned sale
1,434 -100.0%
27.00
US$38,718 		1,434 -100.0% 27.00 US$38,718
2020-07-09 2020-07-07
PlS Planned sale
6,510 -100.0%
26.00
US$169,260 		6,510 -100.0% 26.00 US$169,260
2020-07-09 2020-07-07
PlS Planned sale
5,232 -100.0%
27.00
US$141,264 		5,232 -100.0% 27.00 US$141,264
2020-06-22 2020-06-22
S Sale
5,000 -100.0%
24.00
US$120,000 		5,000 -100.0% 24.00 US$120,000
2020-06-22 2020-06-22
S Sale
5,000 -100.0%
25.00
US$125,000 		5,000 -100.0% 25.00 US$125,000
2020-06-17 2020-06-17
S Sale
2,741 -100.0%
23.00
US$63,043 		2,741 -100.0% 23.00 US$63,043
2020-06-17 2020-06-17
S Sale
4,166 -100.0%
23.00
US$95,818 		4,166 -100.0% 23.00 US$95,818
2020-06-15 2020-06-15
S Sale
6,666 -100.0%
22.00
US$146,652 		6,666 -100.0% 22.00 US$146,652
2020-06-12 2020-06-12
S Sale
4,166 -100.0%
21.10
US$87,903 		4,166 -100.0% 21.10 US$87,903
2020-06-12 2020-06-12
S Sale
10,879 -100.0%
20.77
US$226,005 		10,879 -100.0% 20.77 US$226,005
2014-10-24 2014-10-23
B Purchase
18,200 +219.3%
1.59
US$28,998 		18,200 +219.3% 1.59 US$28,998
2014-10-24 2014-10-22
B Purchase
8,300 +inf%
1.52
US$12,651 		8,300 +inf% 1.52 US$12,651